The past 6 months have been difficult for the developers of CCR5 antagonists. First, GlaxoSmithKline halted Phase III studies of aplaviroc because of serious hepatotoxicity (ACC Sep 28 2005), and then ...
In a recent study published in the Clinical Infectious Diseases journal, researchers assessed the impact of long coronavirus disease 2019 (COVID-19) on C-C chemokine receptor-5 (CCR5) and ...
This post was last updated August 4 at 7:43 p.m. UCLA researchers have discovered a molecular explanation that describes how the brain links multiple memories as well as a potential treatment for ...
Jay Lalezari, CEO of CytoDyn, explains how the CCR5 receptor has emerged as a pivotal target in metastatic cancers due to its dual role in promoting tumor cell migration and shaping a protective tumor ...
The new Science Express study reveals the structure of the CCR5 cell surface receptor, which most strains of HIV use to enter human immune cells. This image shows CCR5 side-by-side with alternate HIV ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--IncellDx today announced it has been granted U.S. Patent No. 11,180, 491 by the U.S. Patent and Trademark Office (“USPTO”) for methods of treating coronaviruses ...
Our brains lose the ability to link related memories as we age. Scientists genetically restored this brain function in middle-aged mice and identified an FDA-approved drug that achieves the same thing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback